| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_9816bfefb8753ca45c99e459ba1df545 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12R2001-645 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-28
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K36-068
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N1-145 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K36-07
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-28 |
| filingDate |
2020-07-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_95c43207addd6e8417c7dc5398312e9f
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b969ba38544b29a785ac80a0c1f83507
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c11651a41eb151752571a998a546b748 |
| publicationDate |
2021-02-18-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
JP-2021020895-A |
| titleOfInvention |
Cordyceps sinensis CS-100 strain and its use for treating or preventing diseases related to abnormal proteins in nerve cells |
| abstract |
PROBLEM TO BE SOLVED: To obtain a Cordyceps sinensis CS-100 strain and an application using the same for treating or preventing a disease related to an abnormal protein in a nerve cell. SOLUTION: The present invention has a deposit number CGMCC No. to the Ordinary Microbial Center of the China Microbial Species Storage Management Committee. The new Cordyceps sinensis CS-100 strain deposited as 14350 on July 7, 2017 is disclosed. The Cordyceps sinensis CS-100 strain can be used not only to effectively and specifically suppress the accumulation of QN1 protein and / or TDP-43 protein, but also to promote synaptic regeneration, thereby causing nerves. The effect of treating or ameliorating diseases related to abnormal proteins in cells is achieved. [Selection diagram] Fig. 1 |
| priorityDate |
2019-07-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |